Work

Abstract 1171: M9466 (HRS-1167): A highly potent and selective PARP1 inhibitor with DNA trapping activity, monotherapy antitumor activity and synergistic potential with DDR inhibitors and chemotherapies

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1171

Authors: Heike Dahmen, Ada Sala Hojman, Steffie Revia, Xin Li, Ting Zhang, Nina Berges, Astrid Zimmermann, Thomas Grombacher, Brian Elenbaas

Institutions: Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409635996

Cites:

Cited by: 1

Related to: 10